IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. - Wikidata - wikimedia - TriplyDB

IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain.

IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain.

http://www.wikidata.org/entity/Q42573892

about

Glycogen synthase kinase 3: a point of convergence for the host inflammatory response Structure and signalling in the IL-17 receptor family The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity IL-17 family: cytokines, receptors and signaling Lithium controls central nervous system autoimmunity through modulation of IFN-γ signaling The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing The IL-17 pathway as a major therapeutic target in autoimmune diseases The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).IL-17 activates the canonical NF-kappaB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16.Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity.SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling.AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1 Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression.IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction.IL-17A signaling in colonic epithelial cells inhibits pro-inflammatory cytokine production by enhancing the activity of ERK and PI3K.Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.Recent advances in the IL-17 cytokine family.IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of Dermatitis Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages.IL-17 in obesity and adipogenesis.Morphine compromises bronchial epithelial TLR2/IL17R signaling crosstalk, necessary for lung IL17 homeostasis C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins.MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation.CCAAT/Enhancer-binding protein β promotes pathogenesis of EAE.TRAF6-dependent Act1 phosphorylation by the IκB kinase-related kinases suppresses interleukin-17-induced NF-κB activation Cytotoxic effector functions of T cells are not required for protective immunity against fatal Rickettsia typhi infection in a murine model of infection: Role of TH1 and TH17 cytokines in protection and pathology.C/EBPβ regulates multiple IL-1β-induced human astrocyte inflammatory genes.IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors.TRAF molecules in cell signaling and in human diseases Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.Insulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action.IL-17 signaling in host defense and inflammatory diseases.Signaling of interleukin-17 family cytokines in immunity and inflammation.IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease.

P2860

Q24597129-E954D47E-36F3-4A70-A318-EBDEF28CF81F Q24648045-6790FB55-455B-47DE-9C34-7DF494F570A2 Q26750673-78C2E108-CB6D-4831-B163-21979EDEC269 Q26860251-1E007BDC-4C7F-4B4D-872C-51A876839D2A Q27324211-018441BF-4689-4558-873D-E66D2133DE66 Q27687800-074C8394-4FA0-4807-A52E-70264FCC57F1 Q28300826-A805DCED-5D6C-4C23-9AFC-C49D8F364E60 Q28589412-3214F7D2-05E3-46DF-8729-5270DE0ACF68 Q30664773-1839AD13-CCE8-4478-BC57-C493EFEEEAF0 Q31090776-0A62FC27-5441-47FB-9CA3-877F8DCE7185 Q33636704-022584A9-046A-4EB1-A0CB-E011421C7522 Q33767461-728DC8FC-996B-4EED-A2A5-6FF1DD805AFE Q33894387-CB7E0475-1DF5-4AA2-9FEE-79B9F4229BFE Q34236471-24E9561E-234A-45E5-ABBC-C934A8CF45F2 Q34340648-DDF8AEC5-13E9-416B-87E6-DE1329C8CD98 Q34595624-B3ECA1D6-F7C0-4791-AADB-197562E80260 Q34607184-3A07F36C-0E95-4695-80F5-A9324091FB16 Q34787020-FC463C7C-02EC-45F8-896C-D0F10696F604 Q34906387-ECDCDAF9-D423-4384-BB65-F67D9E0840AF Q35107947-B3EF6C56-D0C8-4995-8A19-A52BA004B810 Q35240439-0E21114C-1427-4E3A-8A7A-CF05EE38C748 Q35301277-D48C7390-2AAB-4B7B-BF97-CA15F3A0E34E Q35513889-0ED2BA7C-C033-48A4-818F-983BACCD68A8 Q35653856-2E5EF588-8CCE-4FCC-A84F-A1E89D42B731 Q35673437-E382AD13-A212-40BC-AABD-FC6618758853 Q35676503-B87BD202-F359-406B-BDAB-70B28C43B10C Q35740784-1A0DD75C-695F-421A-AFE0-756E65AC4CC1 Q35758463-1BE4D64F-87A1-48CE-B37E-817C7A384DAB Q36073357-77AF1FF0-29D1-4509-AB1F-37A0A08497B8 Q36249964-8D146AFF-50AC-42DD-9362-E3E8E8FA1DD1 Q36277273-CBB1AAB2-318B-4090-A9C7-9D913737D982 Q36286343-15707E98-50BF-4D29-BE86-76AF273E73FC Q36299169-451D5F5B-B0E7-4E9E-B415-BFF5E551EC50 Q36678031-0D30E768-6AF7-4856-90C0-66759BE66718 Q36972287-B79D25BA-531C-471F-B7B8-5F804E6CEA6F Q37046424-8FA419A1-941B-4622-BB2F-0EA04C4BD47A Q37230842-FA2A8AF4-B686-400A-99BF-4DA419AA77B2 Q37728649-4EAF8FB0-4F9E-4ECC-8779-63FD0E749A90 Q37815900-B151D3E7-45E3-4BDC-898C-C2A7A3A15798 Q37865163-EE498B2A-19D7-4E7B-97A5-4A3687CD4527

P2860

IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain.

http://www.wikidata.org/entity/Q42573892

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

IL-17 receptor signaling inhib ...... on of the regulatory 2 domain.

@en

IL-17 receptor signaling inhib ...... on of the regulatory 2 domain.

@nl

type

label

IL-17 receptor signaling inhib ...... on of the regulatory 2 domain.

@en

IL-17 receptor signaling inhib ...... on of the regulatory 2 domain.

@nl

prefLabel

IL-17 receptor signaling inhib ...... on of the regulatory 2 domain.

@en

IL-17 receptor signaling inhib ...... on of the regulatory 2 domain.

@nl

P1433

Q42573892-28A31810-8FD4-4B35-8185-08D3F59F9A85

P1476

Q42573892-8637C3F2-E080-4C35-B60C-9F02BF34AAA6

P2093

Q42573892-48819354-C5D2-4610-8EF8-7A93A5BBD3C9

Q42573892-59B35A77-85DD-44A5-981A-89426FBEA749

Q42573892-8689D773-D119-42A0-8A96-07BC2707F795

Q42573892-BE6813AB-ED5E-40DF-991E-6C536B6C99E7

Q42573892-CFCD033F-14F2-402A-B152-A4A9BA7C06C4

Q42573892-E597E93D-351A-4000-B301-7CE9F758B351

P2860

Q42573892-095D5519-F194-462B-8926-441744BAC322

Q42573892-09D18750-D6DC-4885-B038-42A9728918FB

Q42573892-0C7287BC-EE3F-4784-A1C9-79A0EA84A795

Q42573892-29FB540F-E1DA-4D2F-86A1-8861CDE8B8FA

Q42573892-371FBF0D-4429-4B48-B954-362708D3F995

Q42573892-4A27D1B9-1BA2-410C-B8DC-D870EB57A7B8

Q42573892-4D9ED252-1E74-45DF-923F-CC3F24139E2B

Q42573892-4E6A2238-72C8-46B6-B5E3-28892BBEFF1C

Q42573892-56979977-CCF1-43AB-B380-14D6FD0EACDB

Q42573892-5B702166-C8FF-431D-A2A5-B62B83427A75

P304

Q42573892-F3813C36-4936-4428-9805-68D6AA7E2230

P31

Q42573892-34A4E42A-327C-4A60-BCC3-DD59BB4525E0

P356

Q42573892-693684FF-63D8-4450-B3E4-C571197FE708

P433

Q42573892-DE122E02-C8B7-48B5-948B-219F97E9D7C1

P478

Q42573892-8B1C27C8-6540-411A-9F54-2F53C2D8DC6D

P50

Q42573892-064D86C0-C622-46B9-9377-21C510D76C5B

Q42573892-A72D1B86-BFA8-4DD2-8978-E7A8506F5048

Q42573892-DC206F2F-BFDB-4AFA-9B84-279212E809A4

P577

Q42573892-F08ABE4F-0D99-476D-9C5E-CCDA630B684D

P5875

Q42573892-2B78C8FA-D714-4A0A-B23F-549364CED96E

P698

Q42573892-F0570522-FB7B-43EC-A98A-C575EED8B496

P921

Q42573892-92C0B73A-3E5E-469A-9780-21C559B02699

P932

Q42573892-16EC2556-43D1-4D54-92BE-362F727578F7

P356

SCISIGNAL.2000066

P1433

Science Signaling

P1476

IL-17 receptor signaling inhib ...... on of the regulatory 2 domain.

@en

P2093

Dhananjaya V Kalvakolanu

http://www.w3.org/2001/XMLSchema#string

Fang Shen

http://www.w3.org/2001/XMLSchema#string

Nan Li

http://www.w3.org/2001/XMLSchema#string

Padmaja Gade

http://www.w3.org/2001/XMLSchema#string

Sarah L Gaffen

http://www.w3.org/2001/XMLSchema#string

Timothy Weibley

http://www.w3.org/2001/XMLSchema#string

P2860

CCAAT/enhancer-binding proteins: structure, function and regulation

Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression

Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

Interleukin-17 family and IL-17 receptors

IL-17: prototype member of an emerging cytokine family

Cutting edge: interleukin 17 signals through a heteromeric receptor complex

Cytokines in the pathogenesis of rheumatoid arthritis

IL-17 family cytokines and the expanding diversity of effector T cell lineages

Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis

P304

ra8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCISIGNAL.2000066

http://www.w3.org/2001/XMLSchema#string

P433

59

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

James R. Woodgett

Bradley W. Doble

P577

2009-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225083070

http://www.w3.org/2001/XMLSchema#string

P698

19244213

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

2754870

http://www.w3.org/2001/XMLSchema#string